A Comparison of Emtricitabine and Stavudine Used With Didanosine Plus Efavirenz in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs
- Conditions
- HIV Infections
- Registration Number
- NCT00006208
- Lead Sponsor
- Triangle Pharmaceuticals
- Brief Summary
The purpose of this study is to compare the safety and effectiveness of emtricitabine and stavudine when given with didanosine plus efavirenz to HIV-infected patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- Not specified
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (63)
Univ of Alabama at Birmingham
🇺🇸Birmingham, Alabama, United States
East Bay AIDS Ctr
🇺🇸Berkeley, California, United States
East Bay Clinical Trial Ctr
🇺🇸Concord, California, United States
Mem Med Group Inc
🇺🇸Long Beach, California, United States
AIDS Healthcare Foundation
🇺🇸Los Angeles, California, United States
Orange Coast Med Group
🇺🇸Newport Beach, California, United States
St Lukes Medical Group
🇺🇸San Diego, California, United States
Robert Smith Medical Group
🇺🇸San Diego, California, United States
Saint Francis Mem Hosp / HIV Care
🇺🇸San Francisco, California, United States
Davies Med Ctr
🇺🇸San Francisco, California, United States
Scroll for more (53 remaining)Univ of Alabama at Birmingham🇺🇸Birmingham, Alabama, United States